Spinal Mets Webinar
rule

JOIN US FOR A LIVE WEBINAR

Title: Combination of Targeted Therapies and SBRT for the Treatment of Metastatic Non-Small Cell Lung Carcinoma
Presenter: Kimberley S. Mak, MD, MPH
Presenter: Gregory M.M. Videtic, MD, CM, FRCPC
Moderator: David Palma, MD, MSc, PhD, FRCPC
Date: Monday, April 24, 2017
Time: 12:00pm ET / 9:00am PT
Where: Your Computer and/or Telephone
Description
Descriptor to go here.

Objectives
After attending this activity, participants should be able to understand and describe:
 
    • Objective 1.
    • Objective 2.
    • Objective 3.
    • Objective 4.
Presenters and Moderator

Kimberley S. Mak, MD, MPH, is an Assistant Professor of Radiation Oncology at the Boston University School of Medicine and its affiliate Boston Medical Center. She received her MPH from Harvard School of Public Health (2015), MD from Harvard Medical School (2010) and AB summa cum laude in Biochemical Sciences from Harvard College (2005). Dr. Mak completed an internship in Internal Medicine at Brigham and Women’s Hospital (2011)l, followed by residency in the Harvard Radiation Oncology Program (2015), training at Massachusetts General Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Children’s Hospital of Boston, and Boston Medical Center. Dr. Mak has board certification in Radiation Oncology by the American Board of Radiology. She speaks English and Cantonese. Her specialties include thoracic, gastrointestinal, gynecologic, and musculoskeletal malignancies. She leads the Cyberknife® radiosurgery program for thoracic and gastrointestinal malignancies.

Her research interests include patient-reported outcomes including quality of life; disparity outcomes research; translational research; intensity-modulated and image-guided radiotherapy; CyberKnife® stereotactic radiotherapy; and functional imaging in radiotherapy. She has training and experience in biostatistics, epidemiology, decision analysis, meta-analysis, clinical trial design, and molecular and cell biology laboratory work.

Gregory M.M. Videtic, MD, CM, FRCPC, received his medical degree from McGill University Faculty of Medicine in Montreal, Quebec, Canada. He completed a first residency in family medicine at Dalhousie University in Halifax, Nova Scotia. He later carried out a clinical research fellowship in geriatrics at the University of Western Ontario, London, Ontario.

A two-year position as a Hospitalist at the Nova Scotia Cancer Centre in Halifax was followed by residency training in radiation oncology at the University of Western Ontario. Under the mentorship of Dr. Laurie Gaspar, he completed a CNS radiosurgery/brachytherapy fellowship at Wayne State University in Detroit, MI.

He has been a Staff Physician at the London Regional Cancer Centre, London, Ontario; the Dana-Farber Cancer Institute, Boston, Mass.; and is currently Section Head for Thoracic Malignancies and Residency Program Director in the Department of Radiation Oncology at Cleveland Clinic.

His specialty interests include radioprotectants, radiosensitizers, stereotactic body radiotherapy, altered fractionation and treatment toxicity.

David Palma, MD, MSc, PhD, FRCPC, Dr. David Palma is a Radiation Oncologist at the London Health Sciences Centre and a Clinician-Scientist with the Ontario Institute for Cancer Research. He specializes in the treatment of thoracic cancers, head and neck cancers, and oligometastatic disease.

He holds a BSc from Queen’s University (Canada), an MD from the University of Western Ontario (Canada), a Master’s Degree in Epidemiology from the Harvard School of Public Health, and a PhD from the VU University Medical Center (Netherlands). He completed his residency training at the University of British Columbia.

Dr. Palma's research focuses on translational imaging science, including evaluating new imaging and radiotherapy technologies in the pre-clinical and clinical setting. He currently leads or co-leads several clinical trials. He is the chair of the Canadian Pulmonary Radiotherapy Investigators (CAPRI) Group.

Dr. Palma has published over 100 peer-reviewed scientific articles and is also the founder of the patient information website www.qualitycancertreatment.com, which focuses on empowering patients to obtain the best quality cancer care possible.


Live Webinars are free to anyone interested in learning about SRS/SBRT. Please note the following: 
    • Access to recorded webinars is limited to RSS members only.
    • CMEs for attending live webinar broadcasts are available to physicians and are at no cost to RSS physician members.
    • CMEs for attending live broadcasts are available to physicians that are non-RSS members for $12.95. 
    • For purposes of documenting CME attendance, each person must register individually and attend the entire broadcast. Certificates of Attendance will be issued based on these registration requirements, no exceptions.

CME Live Activity Overview (Physicians Only)

To be eligible for documentation of CME credit, physicians must attend the entire live webinar and complete an evaluation form. All physician attendees will be contacted after the live webinar with CME evaluation information and any associated fee. Although we cannot provide CE at this time for all medical professionals due to limited staffing and financial resources, we are currently working with organizations to offer CE in the future.

For questions regarding this educational activity, please call 408.385.9411.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AMEDCO and the Radiosurgery Society (the RSS). AMEDCO is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

AMEDCO designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Member login  
rule

ABSTRACT SUBMISSION DEADLINE
Saturday, April 1, 2017



   
the RSS would like to
acknowledge and thank our 
Corporate Sponsors.

    

the RSS would like to 
acknowledge and thank our 
Academic & Hospital and
Free-Standing & Private Practice
Sponsors.






  
the RSS is pleased to collaborate with the following:







Interact With Us!
facebook Like our Facebook Page   
Join our Facebook Group
twiter Follow us on Twitter 
Follow our Group on LinkedIn
Visit our Journal on Cureus
Skype Me™!  Call us on Skype
divider